TACSTD2 and cancer: In right‐sided CRC, TROP2 expression was associated with impaired OS (p = 0.05, HR = 1.37), DSS (p = 0.014, HR = 1.58), and DFS (p < 0.001, HR = 2.03, Figure 3), whereas no survival differences were observed in left‐sided cancers (OS, DSS, DFS: p > 0.05, respectively).